Advanced Squamous Cell Carcinoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 36026
Special Issue Editor
Special Issue Information
Dear Colleagues,
Squamous cell carcinomas (SCCs), known as epidermoid carcinomas, comprise a number of different types of cancer that result from squamous cells. These cells form on the surface of the skin, on the lining of hollow organs in the body, and on the lining of the respiratory and digestive tracts.
Surgical resection is one of the standards of care for locally advanced SCC, and recent development of surgical devices, equipment, and techniques could improve treatment outcomes. Additionally, considering the quality of life, a non-surgical approach such as chemoradiotherapy is a less invasive treatment option to preserve organ function because SCC often develops at the organ with a complicated anatomical structure. Moreover, a multidisciplinary approach such as neoadjuvant and induction chemotherapy followed by surgery could improve short- and long-term outcomes. In terms of metastatic SCC, the current development of chemotherapy and chemoradiotherapy provides favorable survival outcomes. Moreover, the introduction of immune checkpoint inhibitors is reported to be effective to improve the treatment outcomes.
This Special Issue will provide a comprehensive overview and novel insights on the diagnosis and treatment of advanced SCC.
Dr. Seiichiro Abe
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- squamous cell carcinoma
- surgery
- chemotherapy
- radiotherapy
- multidisciplinary